Premaitha is a molecular diagnostics company that has developed and launched a non-invasive prenatal test (NIPT), targeted initially at ex-US markets; the company is primarily products-based, addressing the needs of its laboratory customers. Differentiated from other NIPTs by a faster turnaround time, a reduced need to re-run tests (failure rate), the fact that the test is CE marked and that it matches the specifications of National screening programmes, Premaitha is well placed to capitalise ....